Biologics and Injectables Index

Convert Unblinded Payer Perceptions into Insights

Track current and emerging trends about biologics and injectables with perspectives from payers, HCPs, office managers, representing 75% of Commercial and Medicare lives. Capture unblinded payer perceptions to drive insightful action.

Learn More


icon-website

Examine

Examine payer reactions to relevant topics affecting healthcare each quarter.

icon-website

Assess

Assess high level payer management techniques, site of care dynamics, and administration burden via Access Management Topics.

icon-website

Review

Review a deep dive of specific therapeutic areas, including analysis of disruptive events and payer perceptions of new or emerging therapies.

icon-website

Understand

Understand perspectives from key payer stakeholders representing 75% of Commercial and Medicare lives.

Features

How We Help

MMIT's Biologics and Injectables Index gathers insights through field research with its industry-leading panel of pharmacy decision-makers at health plans, PBMs, providers and integrated delivery systems. 100% of panelists are either active P&T participants or control access for pharmaceuticals for their organizations, giving you unparalleled visibility into these entities.

Understand

Understand which biologic and injectable agents are more commonly prescribed by HCPs and their familiarity with upcoming launches.

Uncover

Uncover patient concerns that are most commonly discussed with their physician when looking for new starts on biologic and injectable therapies or when being forced to switch.

Review

Review Practice Manager and HCP perception of administration burden for each brand.

Observe

Observe anticipated coverage changes within a payer organization over time for its Commercial and Medicare lines of business.